1. Home
  2. CDZI vs ALT Comparison

CDZI vs ALT Comparison

Compare CDZI & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDZI
  • ALT
  • Stock Information
  • Founded
  • CDZI 1983
  • ALT 1997
  • Country
  • CDZI United States
  • ALT United States
  • Employees
  • CDZI N/A
  • ALT N/A
  • Industry
  • CDZI Water Supply
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CDZI Utilities
  • ALT Health Care
  • Exchange
  • CDZI Nasdaq
  • ALT Nasdaq
  • Market Cap
  • CDZI 453.8M
  • ALT 501.9M
  • IPO Year
  • CDZI N/A
  • ALT N/A
  • Fundamental
  • Price
  • CDZI $5.62
  • ALT $4.96
  • Analyst Decision
  • CDZI
  • ALT Strong Buy
  • Analyst Count
  • CDZI 0
  • ALT 7
  • Target Price
  • CDZI N/A
  • ALT $16.33
  • AVG Volume (30 Days)
  • CDZI 1.2M
  • ALT 3.2M
  • Earning Date
  • CDZI 11-13-2025
  • ALT 11-06-2025
  • Dividend Yield
  • CDZI N/A
  • ALT N/A
  • EPS Growth
  • CDZI N/A
  • ALT N/A
  • EPS
  • CDZI N/A
  • ALT N/A
  • Revenue
  • CDZI $15,979,000.00
  • ALT $20,000.00
  • Revenue This Year
  • CDZI $58.18
  • ALT N/A
  • Revenue Next Year
  • CDZI $32.89
  • ALT N/A
  • P/E Ratio
  • CDZI N/A
  • ALT N/A
  • Revenue Growth
  • CDZI 188.33
  • ALT N/A
  • 52 Week Low
  • CDZI $2.13
  • ALT $2.90
  • 52 Week High
  • CDZI $6.49
  • ALT $10.88
  • Technical
  • Relative Strength Index (RSI)
  • CDZI 54.91
  • ALT 71.52
  • Support Level
  • CDZI $5.44
  • ALT $4.40
  • Resistance Level
  • CDZI $6.40
  • ALT $4.75
  • Average True Range (ATR)
  • CDZI 0.44
  • ALT 0.29
  • MACD
  • CDZI 0.05
  • ALT 0.08
  • Stochastic Oscillator
  • CDZI 53.88
  • ALT 98.45

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: